Latest debt-to-equity ratio
Cogent Biosciences Debt-to-equity ratio
Direct answer
Cogent Biosciences's debt-to-equity ratio is 45.88%.
The verified market snapshot reports 45.88%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free Cogent Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 45.88%
Explore related company data
View Cogent Biosciences's market capitalizationView Cogent Biosciences's price-to-book ratioView Cogent Biosciences's return on equityView Cogent Biosciences's dividend yieldView Cogent Biosciences's 52-week price rangeView Cogent Biosciences's profit marginView all Cogent Biosciences key metricsReturn to Cogent Biosciences profile